The study included 409 patients from primary care practice in the Netherlands and Switzerland. The researchers assessed PA using the Longitudinal Ageing Study Amsterdam Physical Activity Questionnaire at baseline and followed patients for up to 5 years. During follow-up, patients reported their comorbidities (cardiovascular, neurological, hormonal, musculoskeletal, cancer, and infectious diseases) and completed the Hospital Anxiety and Depression Scale questionnaire for mental health assessment.
The authors conclude: “In COPD patients, those with high PA are less likely to develop depression or anxiety over time. PA promotion programs may be considered to lower the burden of mental disorders in COPD patients.”
They add: “These findings have particular significance since mental disorders are common in patients with COPD. The prevalence of depression and anxiety is approximately 40% in COPD patients while the corresponding figure is less than 10% in the general population.”